K-VOG Tablets

For The Use Of A Registered Medical Practitioner, A Hospital Or A Laboratory Only.
COMPOSITION
K-VOG 0.2 mg Tablets
Each Uncoated Tablet Contains:
Voglibose 0.2 mg
K-VOG 0.3 mg Tablets
Each Uncoated Tablet Contains:
Voglibose 0.3 mg
INDICATIONS
1. Prevention of onset of type 2 DM in subjects with impaired glucose tolerance (IGT).
2. Improvement of postprandial hyperglycemia in diabetes mellitus.
DOSAGE AND ADMINISTRATION
Oral: Adults: 0.2 – 0.3 mg three times a day before each meal, or as prescribed.
HOW SUPPLIED
10 Tablets per strip.